RKB-32478-38758
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 967 / HI
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
-
2021-01-06
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-07
- 2021-01-08
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-27
-
2021-02-03
Dose 2 — Moderna
- 2021-02-17
- 2021-02-24
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Uterine cancer — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Uterine cancerMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 2
Symptoms: Uterine cancer
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Uterine cancer | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release